[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (8): 836-842.doi: 10.3736/jcim20080813

• Original Experimental Research • Previous Articles     Next Articles

Effects of Buyang Huanwu Decoction and its alkaloids and glycosides on aortic intimal hyperplasia and expression of proliferating cell nuclear antigen in rats with aortic intimal injuries

Lu Wu, Wei Zhang, Hua Li, Guo-min Zhang, Bei-yang Chen, Ying-hong Tang, Chang-qing Deng()   

  1. Laboratory of Pathophysiology, Hunan University of Traditional Chinese Medicine, Changsha, Hunan Province 410007, China
  • Received:2007-12-26 Online:2008-08-20 Published:2008-08-15

RichHTML

1

PDF (PC)

174

Like

Objective: To explore the effects of alkaloids and glycosides extracted from Buyang Huanwu Decoction (BYHWD), a compound of traditional Chinese herbal medicine, on aortic intimal hyperplasia and the expression of the proliferating cell nuclear antigen (PCNA) in rats with aortic intimal injuries.
Methods: The vessel restenosis model was established by denuding aortic endothelium with domestic balloon catheter in rats. Drugs were administered intragastrically on the first day after operation. The injured segments of aorta were taken on the fifteenth day after operation to determine the degree of intimal hyperplasia and observe the expression of PCNA.
Results: Aortic intimal hyperplasias were very obvious on the fifteenth day after operation. The media hyperplasias in the drug-treated groups were not significant (P>0.05),but the intimal hyperplasia were remarkable as compared with that in the sham-operated group (P<0.01). The degrees of intimal hyperplasia in BYHWD, alkaloids, glycosides and atorvastatin groups were less than that in the untreated group (P<0.01). There was significant difference of PCNA expression between the untreated group and the sham-operated group (P<0.01). The expressions of PCNA in alkaloids, glycosides, and atorvastatin groups were higher than that in the sham-operated group (P<0.01, P<0.05), but still lower than that in the untreated group (P<0.01). The expression of PCNA in BYHWD group was higher than that in the sham-operated group (P<0.01), and no significant difference was found between the BYHWD group and the untreated group (P>0.05).
Conclusion: Alkaloids and glycosides extracted from BYHWD can inhibit intimal hyperplasia induced by denuding arterial endothelium with domestic balloon catheter in rats. Alkaloids and glycoside may be among basal substances in BYHWD inhibiting intimal hyperplasia of blood vessel, the effect of which may relate to down-regulating the expression of PCNA.

Key words: Buyang Huanwu Decoction, alkaloids, glycosides, balloon catheter, vascular smooth muscle cell, morphology, proliferating cell nuclear antigen

CLC Number: 

  • R285.5

Figure 1

HPLC determination spectra of BYHWD integral prescription and alkaloids, glycosides extracted from BYHWD A-1: Tetramethylpyrazine; A-2: Alkaloids; A-3: BYHWD. B-1: Astragaloside Ⅳ; B-2: Ferulic acid, amygdalin, paeoniflorin; B-3: Glycosides; B-4: BYHWD."

Figure 2

Vascular morphology of rats in different groups (Light microscopy, ×100) A: Sham-operated group; B: Untreated group; C: Atorvastatin group; D: BYHWD group; E: Alkaloids group; F: Glycosides group. Arrows indicate the region of intimal hyperplasia."

Table 1

Measurement parameters of vascular morphology and expressions of PCNA of rats in different groups（x±s）"

Group n MA (μm2)I A (μm2) IA/MA IA/MA MT (μm)
Sham-operated 10 9 984.30±657.00 0.00±0.00 0.00±0.00 12.24±0.95
Untreated 10 10 705.50±1 716.86 4 173.75±1 804.88** 0.40±0.18** 12.08±1.64
Atorvastatin 10 11 281.85±1 167.10 2 369.25±788.19**△△ 0.21±0.07**△△ 12.97±1.48
BYHWD 10 11 790.45±1 311.26 2 147.80±916.12**△△ 0.18±0.07**△△ 13.33±1.57
Alkaloids 10 12 028.10±1 860.75 1 900.20±572.66**△△ 0.16±0.06**△△ 13.05±1.40
Glycosides 10 11 755.80±1 254.00 1 934.80±735.82**△△ 0.17±0.07**△△ 13.50±1.98
Group n IT/MT HRIA (％) HRIT (％) PCNA IT (μm)
Sham-operated 10 0.00±0.00 0 0 161.4±22.3 0.00±0.00
Untreated 10 0.42±0.19** 27±9** 29±10** 113.7±12.7** 5.01±2.11**
Atorvastatin 10 0.22±0.07**△△ 17±5**△△ 18±5**△△ 136.1±7.2**△△ 2.92±1.07**△△
BYHWD 10 0.19±0.07**△△ 15±5**△△ 16±5**△△ 124.4±18.8** 2.55±1.11**△△
Alkaloids 10 0.17±0.06**△△ 14±4**△△ 14±5**△△ 144.7±17.4*△△ 2.22±0.77**△△
Glycosides 10 0.18±0.07**△△ 14±5**△△ 15±5**△△ 134.8±5.7**△△ 2.36±0.90**△△

Figure 3

PCNA expressions in intima of rats in different groups by immunohistochemistry (Light microscopy, ×400) A: Sham-operated group; B: Untreated group; C: Atorvastatin group; D: BYHWD group; E: Alkaloids group; F: Glycosides group. Arrows indicate the region of intimal hyperplasia."

[1] Wu L, Zhang W, Deng CQ . Study on intimal hyperplasia model induced by domestic balloon catheter in rats with aortal lesion and its characters[J]. Hunan Zhong Yi Yao Da Xue Xue Bao, 2007,27(5):20-23
doi: 10.3969/j.issn.1674-070X.2007.05.008
吴露, 张伟, 邓常青 . 国产球囊导管制作大鼠主动脉损伤血管内膜增生模型及特性的研究[J]. 湖南中医药大学学报, 2007,27(5):20-23
doi: 10.3969/j.issn.1674-070X.2007.05.008
[2] Tang YH, Liang Y, Zhang SP , et al. Effect of Buyang Huanwu decoction and its alkaloid and glycoside on anticoagulative system arterial thrombosis rat[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2007,13(6):39-42
doi: 10.3969/j.issn.1005-9903.2007.06.016
唐映红, 梁燕, 张淑萍 , 等. 补阳还五汤及其有效组分生物碱和苷对动脉血栓形成大鼠抗凝系统活性的影响[J]. 中国实验方剂学杂志, 2007,13(6):39-42
doi: 10.3969/j.issn.1005-9903.2007.06.016
[3] Ji B, Geng P, Liu JG , et al. Effects of active components extracted from Qixue Bingzhi Recipe on proliferation of vascular smooth muscle cells and expressions of platelet-derived growth factor and its receptor genes[J]. Zhong Xi Yi Jie He Xue Bao, 2006,4(1):30-34
嵇波, 耿萍, 刘剑刚 , 等. 气血并治方有效组分配伍对平滑肌细胞增殖和血小板源生长因子及其受体基因表达的影响[J]. 中西医结合学报, 2006,4(1):30-34
[4] Manabe I, Nagai R . Regulation of smooth muscle phenotype[J]. Curr Atheroscler Rep, 2003,5(3):214-222
doi: 10.1007/s11883-003-0027-9 pmid: 12667435
[5] Yoshida T, Owens GK . Molecular determinants of vascular smooth muscle cell diversity[J]. Circ Res, 2005,96(3):280-291
doi: 10.1161/01.RES.0000155951.62152.2e
[6] Wang MH, Xu DL . Cyclin and cyclin-dependent kinase(CDK) inhibitor in the proliferation of vascular smooth muscle cell[J]. Xin Xue Guan Bing Xue Jin Zhan, 2000,21(2):107-110
doi: 10.3969/j.issn.1004-3934.2000.02.015
汪明慧, 许顶立 . 细胞周期素及CDK抑制蛋白与血管平滑肌细胞增殖[J]. 心血管病学进展, 2000,21(2):107-110
doi: 10.3969/j.issn.1004-3934.2000.02.015
[7] Xie QJ, Hou C, Wu WK , et al. Study on platelet-derived growth factor mRNA and copper-zinc superoxide dismutase mRNA expression changes of aortic artery endothelium with restenosis after aortic artery dilatation treated with Buyang Huanwu decoction[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1997,17(10):611-613
doi: 10.7661/CJIM.1997.10.611
谢全锦, 侯灿, 吴伟康 , 等. 补阳还五汤对球囊扩张主动脉后再狭窄其内皮PDGFR和SOD-1基因表达的探讨[J]. 中国中西医结合杂志, 1997,17(10):611-613
doi: 10.7661/CJIM.1997.10.611
[8] Hou C, He Q, Li S , et al. Imitative restenosis after percutaneous transluminal coronary angioplasty prevented by Buyang Huanwu decoction in rabbits[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2001,21(5):359-363
doi: 10.7661/CJIM.2001.5.359
侯灿, 何勤, 李松 , 等. 补阳还五汤防止兔模拟经皮冠脉腔内血管成形术后再狭窄的实验研究[J]. 中国中西医结合杂志, 2001,21(5):359-363
doi: 10.7661/CJIM.2001.5.359
[9] Takada M, Tanaka H, Yamada T , et al. Antibody to thrombin receptor inhibits neointimal smooth muscle cell accumulation without causing inhibition of platelet aggregation or altering hemostatic parameters after angioplasty in rat[J]. Circ Res, 1998,82(9):980-987
doi: 10.1161/01.RES.82.9.980
[1] Mei-jiao Mao, Jun-ping Hu, Cong Wang, Yi-yi Zhang, Ping Liu. Effects of Chinese herbal medicine Guanxinkang on expression of PPARγ-LXRα-ABCA1 pathway in ApoE-knockout mice with atherosclerosis. Journal of Chinese Integrative Medicine, 2012, 10(7): 814-820.
[2] Feng Xin-ying, Zhu Min, Zhang Qi-qi, Chen Yi-ping, Li Wen-wei. Selective protection of nigral dopaminergic neurons by echinacoside in a rat model of Parkinson disease induced by rotenone. Journal of Chinese Integrative Medicine, 2012, 10(7): 777-783.
[3] De Arnab, Das Durba, Dutta Suman, Chakraborty Debrup, Boujedaini Naoual, Rahman Khuda-Bukhsh Anisur. Potentized homeopathic drug Arsenicum Album 30C inhibits intracellular reactive oxygen species generation and up-regulates expression of arsenic resistance gene in arsenite-exposed bacteria Escherichia coli. Journal of Chinese Integrative Medicine, 2012, 10(2): 210-227.
[4] Dao-fang Ding , Song-pu Wei, Xiao-feng Li , Xiao-gang Zhang , Hong-sheng Zhan , Tie-li Duan , Yue-long Cao. Inhibition effect of osthole on proliferation of rat chondrocytes. Journal of Chinese Integrative Medicine, 2012, 10(12): 1413-1418.
[5] Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278.
[6] Tao Li-li, Lei Yan. Effects of extracts from Panax ginseng, Panax notoginseng and Ligusticum chuanxiong on expression of β-galactosidase and signal pathway p16-cyclin D/CDK-Rb in vascular smooth muscle cells. Journal of Chinese Integrative Medicine, 2012, 10(1): 76-84.
[7] Han Xiang-hui, Ye Yi-yi, Guo Bao-feng, Liu Sheng. Effects of platycodin D in combination with different active ingredients of Chinese herbs on proliferation and invasion of 4T1 and MDA-MB-231 breast cancer cell lines. Journal of Chinese Integrative Medicine, 2012, 10(1): 67-75.
[8] Anisur Rahman Khuda-Bukhsh, Arnab De, Durba Das, Suman Dutta, Naoual Boujedaini. Analysis of the capability of ultra-highly diluted glucose to increase glucose uptake in arsenite-stressed bacteria Escherichia coli. Journal of Chinese Integrative Medicine, 2011, 9(8): 901-912.
[9] Rui Jin, Bing Zhang, Sen-mao Liu, Chun-miao Xue, Qian Zhao. A mathematical model for re-analysis of the relationship between essence of syndromes in traditional Chinese medicine and clinical biochemical indicators based on the residual-split method and its application. Journal of Chinese Integrative Medicine, 2011, 9(8): 838-846.
[10] Xin Liu, Wei Min . Protective effects of astragaloside against ultraviolet A-induced photoaging in human fibroblasts. Journal of Chinese Integrative Medicine, 2011, 9(3): 328-332.
[11] Qin Bian, Jian-hua Huang, Zhu Yang, You Ning, Yong-jian Zhao, Yong-jun Wang, Zi-yin Shen. Effects of active ingredients in three kidney-tonifying Chinese herbal drugs on gene expression profile of bone marrow stromal cells from a rat model of corticosterone-induced osteoporosis. Journal of Chinese Integrative Medicine, 2011, 9(2): 179-185.
[12] Yang Chen, Jian-hua Huang, You Ning, Zi-yin Shen. Icariin and its pharmaceutical efficacy: Research progress of molecular mechanism. Journal of Chinese Integrative Medicine, 2011, 9(11): 1179-1184.
[13] Gollapalle L. Viswanatha, Hanumanthappa Shylaja, K. Sadashiva Sandeep Rao, Yathiraj Ashwini, V. Ramaiah Santhosh Kumar, C. Gangadharaiah Mohan, Venkate Gowda Sunil, M. Venkateshappa Sarvesh Kumar, Subbanna Rajesh. Amelioration of immobilization stress-induced biochemical and behavioral alterations and mitochondrial dysfunction by naringin in mice: Possible mechanism of nitric oxide modulation. Journal of Chinese Integrative Medicine, 2011, 9(11): 1254-1263.
[14] Li-fang Wang, Jin-feng Wang, Wei-fang Jin, Hong-fu Wang, Shao-fen Zhang, Jian-jun Gao. Effects of daidzein on steroid receptor coactivator-1 expression in MC3T3-E1 cells and the mechanism. Journal of Chinese Integrative Medicine, 2011, 9(11): 1248-1253.
[15] Hai-sheng You , Hai-feng Zhang, Ya-lin Dong, Si-ying Chen, Mao-yi Wang, Wei-hua Dong, Jian-Feng Xing. Absorption and transportation characteristics of scutellarin and scutellarein across Caco-2 monolayer model. Journal of Chinese Integrative Medicine, 2010, 8(9): 863-869.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]